10935 CR 159 – Tyler, TX 75703 – P: (903) 805-9955 F: (903) 839-2494
New Physician Registration Form - Toxicology
Ordering physician’s full name and credentials:______________________ Credentials: _________ Last Name, First Name MD/DO/FNP/PA
Ordering Physician’s NPI #:________________________________________________
Name of Medical Practice:__________________________________________________
Fax # to receive reports: (_____) _______ - _________ Portal Access: Yes No
Name of additional Provider(s) and/or Mid-Level(s):
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
Address for clinic location (s) where orders will be placed and samples will be collected:
Primary Location: __________ City: ____________ State: ______Zip: _______ Street Number & Name Suite
Phone: (______) ________ - ____________ Fax: (______) ________ - ____________
**Information for additional providers and locations on page 2
Specimen Cup: Clear Specimen Collection Cups Point of Care Collection Cups
Anticipated Monthly Volume: ________
Point of Contact Name: ____________________ Phone: ________________ Email: ________________
Processor Needed: Yes / No If yes and currently have one in place:
Name: ______________________; Phone: ___________________; Email: _________________
Implementation Date: ____________________
Hours of Operation (Mon-Wed) Hours of Operations (Thurs-Sat)
Primary Location
(M-W)
Open
Time
Close
Time
UPS Pick-Up
Time
Primary Location
(Th-Sa) Open
Time Close
Time UPS Pick-
Up Time
Mon: Thurs:
Tues: Fri:
Wed: Sat:
Will UPS need to be coordinated: YES NO
**Please mark “NA” for days UPS does not need to pick-up.
Please complete registration form and fax back to (903) 839-2494 or email to
Supply Request(s) or Special Request(s):
10935 CR 159 – Tyler, TX 75703 – P: (903) 805-9955 F: (903) 839-2494
Additional Provider(s) and/or Mid-Levels:
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________ Last Name, First Name
- : ________________________ Credentials: ______ NPI #: _________________
Last Name, First Name
Additional Locations
Additional Location: City: ____________ State: ______Zip: _____ Street Number & Name Suite
Phone: (______) ________ - ____________ Fax: (______) ________ - ____________
Practice Name (If different from Primary): ___________________________________
Additional
Location (M-W) Open Time
Close
Time UPS Pick-Up
Time
Additional
Location (Th-Sa) Open Time
Close
Time UPS Pick-
Up Time
Mon: Thurs:
Tues: Fri:
Wed: Sat:
Will UPS need to be coordinated: YES NO
Additional Location: City: ____________ State: ______Zip:______ Street Number & Name Suite
Phone: (______) ________ - ____________ Fax: (______) ________ - ____________
Practice Name (If different from Primary): ___________________________________
Additional
Location (M-W) Open Time
Close
Time UPS Pick-Up
Time
Additional
Location (Th-Sa) Open Time
Close
Time UPS Pick-
Up Time
Mon: Thurs:
Tues: Fri:
Wed: Sat:
Will UPS need to be coordinated: YES NO
Please complete registration form and fax back to (903) 839-2494 or email to
Advanta Toxicology, LLC Advanta Analytical Laboratories10935 CR 159 I Tyler, TX 75703 Phone: 903.805.9955 I Fax: 903.839.2494
LC/MS Quantitative Analysis - (Please have all physicians/providers initial below)
Generic Names Brand Names Drug Category 6 MAM/Heroin 6 MAM/Heroin Amitriptyline Elavil TCA
Amphetamine Adderall Amphetamine/ Methamphetamine Methamphetamine Desoxyn
Methylphenidate Concerta, Ritalin
Ritalinic acid Butabarbital Barbiturates
Pentobarbital Phenobarbital Clonazepam Klonopin Benzodiazepines Alprazolam Xanax
Chlordiazepoxide Flurazepam Lorazepam Ativan
Diazepam Valium
Oxazepam Serax
Temazepam Restoril
Zolpidem Ambien
Buprenorphine Butrans, Suboxone, Subutex Buprenorphine
Carisoprodol Soma Carisoprodol
Meprobamate Equanil, Miltown
Cocaine/Benzoylecgonine Cocaine/Benzoylecgonine
Cyclobenzaprine Flexeril, Amrix, Fexmid Cyclobenzaprine
Fentanyl Actiq, Duragesic, Fentora, Lazanda
Fentanyl
Gabapentin Neurontin Gabapentin
Ketamine Ketalar Ketamine
MDMA/Ecstasy MDMA/Ecstasy
Meperidine Demerol Meperidine
Methadone Dolophine Methadone
Codeine Tylenol #3 & 4 Opiates
Morphine Avinza, Embeda, Kadian, MS Contin
Hydrocodone Lorcet, Lortab, Norco, Vicodin, Vicoprofen
Oxycodone/Oxymorphone
Oxycodone Oxy-Contin, Percocet, Percodan, Roxicodone, Tylox
Hydromorphone Dilaudid, Exalgo
Oxymorphone Opana
Phencyclidine/PCP Phencyclidine/PCP
Pregabalin Lyrica Pregabalin
Propoxyphene Darvocet, Darvon Propoxyphene
Tapentadol Nucynta Tapentadol
THC/Marijuana THC/Marijuana
Tramadol Ryzolt, Ultram Tramadol
Ethanol (EtOH) Alcohol Ethanol (EtOH)
Provider’s Initials Provider’s Initials_ Provider’s Initials
Provider’s Initials Provider’s Initials_ Provider’s Initials
Advanta Toxicology, LLC Advanta Analytical Laboratories10935 CR 159 I Tyler, TX 75703 Phone: 903.805.9955 I Fax: 903.839.2494
Urine Drug Screen (UDS) testing protocol for:
1. Please review the following UDS order options and select the testing protocol that you wish for Advanta
Toxicology to follow when processing your patient samples.
A. Custom UDS with Quantitative Analysis 1:
Perform Enzyme Immunoassay (EIA) screen and provide qualitative results for the drugs checked
on the attached Test Menu.
Always perform LCMS confirmation for the drugs checked on the attached LCMS Test Menu.
B. Custom UDS with Quantitative Analysis 2:
• Perform Enzyme Immunoassay (EIA) screen for all drugs on attached Test Menu.
• Perform LCMS testing for all positive screen results and/or all prescribed medications listed on the requisition and provide quantitative results
C. Custom UDS with Quantitative Analysis 3:
Perform LCMS testing only for medications listed on LCMS Test Menu and provide quantitative results.
D. Oral Fluid Drug Screening with Quantitative Analysis:
Perform Enzyme Immunoassay (EIA) screen and provide qualitative results for the drugs checked
on the attached Oral Fluid Immunoassay Test Menu.
• Always perform LCMS confirmation for the drugs checked on the Oral Fluid Immunoassay attached Test Menu.
2. Special Instruction Options
A. Alcohol EtG/EtS Isomer Option:
Perform EtG/EtS Isomer testing for all specimens.
B. D&L Isomer Option (for methamphetamines results)
Perform D&L Isomer testing for all positive methamphetamine positive screen results.
C. Suboxone Option - Buprenorphine and expanded Opiates class for Naloxone.
3. Additional order instructions (Please list categories to be confirmed regardless of positive/negative EIA results):
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
Advanta Toxicology, LLC
Advanta Analytical Laboratories
10935 CR 159 I Tyler, TX 75703
Phone: 903.805.9955 I Fax: 903.839.2494
Acknowledgement of Ordering Practitioner
Predefined Customer Profile Attestation
1. It is hereby agreed that the laboratory testing ordered on the laboratory requisition form or through selecting the Standing Order Panel shall only be those tests determined to be clinically indicated and medically necessary.
2. Decisions on ordering laboratory testing are based solely on the medical necessity for a specific medical problem and the results used in the management of a specific medical problem. The provider understands that when ordering tests for which Medicare reimbursement will be sought, the treating provider should only order those tests which the physician believes are medically necessary for each patient. The provider knows that using a Standing Order Panel may result in the ordering of tests for which Medicare or other federally funded health care programs may deny payment. The undersigned providers have been informed that the OIG takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.
3. By singing this form, it is hereby certified that the treating physician shall review the volume, frequency and the duration of testing and order laboratory testing accordingly and in accordance with clinical indication and medical necessity.
4. By signing this form, I acknowledge if any POC device is provided by the lab I will not directly or indirectly bill or collect a fee for POC testing without submitting payment to the lab for the device at a fair market value rate. I agree and understand the device will be used solely to collect, transport, process, or store specimens referred to the lab for testing. I acknowledge and understand that use of the POC for any other purpose or billing for POC testing with laboratory provided POC cups without remitting payment for same to the lab could be interpreted as a violation of Anti-Kickback Statue 42 U.S.C. § 1320a-7b.
5. I acknowledge if any POC device is provided by the lab and I remunerate off any service in which the device is used I will receive an invoice and remit payment for the device at fair market value.
6. If the Standing Order Panel is selected and ordered, the signatories hereto verify that the Standing Order Panel accurately reflects the tests intended to be ordered.
7. The signatories hereto acknowledge that there is no obligation or any restrictions regarding the ordering of testing set forth in the Standing Order Panel.
8. It is agreed that all supporting medical necessity documentation should be legible and maintained in the patient’s medical record.
9. I verify that I am ordering samples for testing to be performed at Advanta Toxicology, LLC and affiliated reference laboratories.
10. The signatories hereto understand there may be applicable National Coverage Determinations and Local Coverage Determinations for Clinical Laboratory Qualitative and Quantitative Drug Testing and Drugs of Abuse Testing.
11. This Standing Order Panel request will be valid for one (1) year from the date of signature, at the end of which time a review and reauthorization will be requested.
I authorize Advanta Toxicology, LLC to follow the protocol listed above when testing patient samples sent to their lab from my clinic(s) unless I instruct otherwise on a signed requisition form. I believe this protocol to be medically necessary and reasonable for my patients. I also acknowledge that Advanta Toxicology, LLC has provided me with information regarding its policies and guidelines for UDS testing.
Practice Name:
Physician’s Printed Name:
Physician’s NPI:
Physician’s Signature: